Sahil Chopra
Directeur/Membre du Conseil chez Indapta Therapeutics, Inc.
Profil
Dr. Sahil Chopra is a Principal at Vertex Ventures HC.
He is on the Board of Directors at Indapta Therapeutics, Inc.
Dr. Chopra was previously employed as a Board Observer by Elevation Oncology, Inc.
He received his undergraduate degree from Maharshi Dayanand University and a graduate degree from Weill Cornell Graduate School of Medical Sciences.
Postes actifs de Sahil Chopra
| Sociétés | Poste | Début |
|---|---|---|
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/01/2023 |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 01/02/2022 |
Anciens postes connus de Sahil Chopra
| Sociétés | Poste | Fin |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/10/2021 |
Formation de Sahil Chopra
| Maharshi Dayanand University | Undergraduate Degree |
| Weill Cornell Graduate School of Medical Sciences | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Finance |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Health Technology |
